The A3-45 trial is researching the safety and effectiveness of an investigational medication in people who might be at increased risk for developing memory loss associated with Alzheimer’s disease. The[…]

Each year, our team looks forward to gathering to support the Alzheimer’s Association’s Walk to End Alzheimer’s. This year, that support looks a little different. Our team members gathered independently, and[…]

November is National Caregiving Month, and we are thrilled to have an initiative that supports dementia caregivers in so many ways. Our Wellness Initiative, which began in 2012 from anonymous[…]